Navigation Links
Hospital for Special Surgery is Only New York Hospital with Significantly Lower Surgical Site Infection Rate for Hip Replacement Compared to State Average
Date:6/30/2009

NEW YORK, June 30 /PRNewswire/ -- A new report on infection rates from the New York State Department of Health singles out Hospital for Special Surgery as the only hospital in New York State with a statistically lower rate of surgical site infection (SSI) compared to the state average for hip replacement/revision surgery.

"We emphasize infection control as a best practice," said Thomas P. Sculco, M.D., surgeon-in-chief of Hospital for Special Surgery, "and strive to maintain it at every level of patient care -- from washing hands to a clean and safe environment for our patients in the operating room and the entire hospital."

The report comparisons also found that hospitals performing fewer than 50 hip replacements/revisions per year had a significantly higher risk for SSI than others. Out of the 171 hospitals in New York State, which collectively performed 23,611 hip replacements/revisions last year, Special Surgery performed almost 3,700, the state's highest surgical volume coupled with a significantly lower SSI rate when compared to the state average.

"At Hospital for Special Surgery, we believe that infection control is everyone's responsibility," said Louis A. Shapiro, President and CEO. "Efforts to prevent infection are woven into the fabric of this organization and it takes everyone's contributions, from surgeons and nurses to housekeepers and technicians, to achieve success."

New York State has one of the strictest regulatory and surveillance systems for hospitals in the country. The law mandates that New York's 186 hospitals document and report certain hospital acquired infections to the New York State Department of Health. The report issued today says key goals are to provide the public with fair, accurate and reliable infection data as well as to support the improvement of infection control activities in hospitals. Today is the second year for the report, but the first to include SSI of hip replacement/revision surgery data.

About Hospital for Special Surgery

Founded in 1863, Hospital for Special Surgery (HSS) is a world leader in orthopedics, rheumatology and rehabilitation. HSS is nationally ranked No. 1 in orthopedics and No. 4 in rheumatology by U.S. News & World Report (2008), and has received Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center. In 2008 and 2007, HSS was a recipient of the HealthGrades Joint Replacement Excellence Award. A member of the NewYork-Presbyterian Healthcare System and an affiliate of Weill Cornell Medical College, HSS provides orthopedic and rheumatologic patient care at NewYork-Presbyterian Hospital at New York Weill Cornell Medical Center. All Hospital for Special Surgery medical staff are on the faculty of Weill Cornell Medical College. The hospital's research division is internationally recognized as a leader in the investigation of musculoskeletal and autoimmune diseases.

    Phyllis Fisher
    fisherp@hss.edu
    212-606-1197

    Tracy Hickenbottom
    hickenbottomt@hss.edu
    212-606-1197


'/>"/>
SOURCE Hospital for Special Surgery
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New research explores newborn in-hospital weight loss
2. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
3. Norwalk virus: Cruise ship illness challenging and costly to hospitals, too
4. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
5. Billy Graham Home After Hospitalization:
6. Alvarado Hospital Files Countersuit Against Blue Shield
7. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
8. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
9. Annual flu shot cuts need for doctors visits, hospitalization among children
10. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
11. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... , ... September 25, 2017 , ... ... Institute is excited to announce the next generation for LASIK in Manhattan with ... of the most technologically advanced laser systems available in the United States to ...
(Date:9/25/2017)... ... September 25, 2017 , ... Dr. Edward Hebert ... “I could not imagine doing anything else,” said Dr. Hebert. “I count my blessings ... day. The interactions with my patients is what I look forward to the most. ...
(Date:9/25/2017)... ... September 25, 2017 , ... “The ... a gripping look at the religious stand in the sensitive matter of ... and compassion. “The Ministry of Reconciliation: A Compassionate and Realistic Approach to Evangelizing ...
(Date:9/25/2017)... , ... September 25, 2017 , ... “The Majestic Unicorn”: ... the great flood. “The Majestic Unicorn” is the creation of published author, Dayna Chantel, ... small, came from far and wide to march aboard the cypress ark-vessel. Male and ...
(Date:9/25/2017)... ... September 25, 2017 , ... The trend-spotters, tastemakers, and ... maker of organic coconut-milk based super herb drinks, with the new NEXTY Gold Award ... the inaugural year for the NEXTY Gold, which is reserved for just those companies ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017 Caris Life Sciences, a leading ... promise of precision medicine, today announced results from ... its molecular profiling approach in guiding therapeutic strategies ... plus (CGP+) with Caris Molecular Intelligence ® ... molecular level, leading to more therapeutic options and ...
(Date:9/6/2017)...  Robert G. Szewc, M.D., is recognized by Continental ... of his contributions to the Medical field.      ... the practice of Kidney and Hypertension Specialists, which specializes ... solutions. He has worked in this position since 2002, ... well as expertise in kidneys, hypertension, chronic disease and ...
(Date:9/6/2017)... Sept. 6, 2017 Eli Lilly and Company ... present new data for galcanezumab and lasmiditan, two investigational ... International Headache Society (IHC) taking place Sept. 7-10 in ... will highlight new, long-term data from an open-label study ... galcanezumab (120 mg and 240 mg) for the prevention ...
Breaking Medicine Technology: